Laboratory News and Research

RSS

Nurses who are interrupted while administering medication make errors: Report

Nurses who are interrupted while administering medication appear to have an increased risk of making medication errors, according to a report in the April 26 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

27 Apr 2010

VCA Antech's first-quarter 2010 revenue up 4.7% to $330.7M

VCA Antech, Inc., a leading animal healthcare company in the United States, today reported financial results for the first quarter ended March 31, 2010 as follows: revenue increased 4.7% to a first quarter record of $330.7 million; gross profit increased to $82.8 million and diluted earnings per common share of $0.37.

27 Apr 2010

ATCC introduces CRMs for method validation and method-performance verification

ATCC announces the launch of Certified Reference Materials, issued under ISO Guide 34 and ISO 17025:2005 accredited and ISO 9001:2008 certified laboratories. As a certified reference material producer, the combined accreditations demonstrate the highest level of quality assurance, accuracy and traceability for ATCC customers.

26 Apr 2010

The Frost Group agrees to make investment in ChromaDex

ChromaDex Corporation, a natural products chemistry company which provides novel and innovative ingredients to the dietary supplement, food, beverage and cosmetic markets, announced today The Frost Group, LLC, led by Miami entrepreneur and billionaire Dr. Phillip Frost, has agreed to make an investment in ChromaDex.

26 Apr 2010

Grape-enriched diet prevents risk factors for metabolic syndrome: Researchers

Scientists at the University of Michigan Health System are teasing out clues to the effect of grapes in reducing risk factors related to cardiovascular disease and metabolic syndrome. The effect is thought to be due to phytochemicals -- naturally occurring antioxidants - that grapes contain.

26 Apr 2010

OICR makes equity investments in three promising Ontario technologies

Frank Stonebanks, Vice-President, Commercialization and Chief Commercial Officer of the Ontario Institute for Cancer Research today announced that OICR has made equity investments in three promising Ontario technologies to accelerate their commercialization.

26 Apr 2010

Bruker to supply customized N8 TITANOS large sample AFM to US Commerce Department's NIST

Bruker today announced that it has been awarded a $1.1 million contract to supply a customized N8 TITANOS™ large sample Atomic Force Microscope (AFM) to the United States Commerce Department's National Institute of Standards and Technology (NIST). The instrument will be used by NIST's Precision Engineering Division (PED) at its Manufacturing Engineering Laboratory, with a main focus on metrology applications which require traceable AFM (T-AFM).

26 Apr 2010

IRIS International announces renewal of supply agreement with MedAssets Supply Chain Systems

IRIS International, Inc., a leading manufacturer of urinalysis systems and consumables for use in hospitals and commercial laboratories worldwide, today announced that it has renewed a supply agreement for its full product line of automated and semi-automated urinalysis systems, related products, consumables and services agreements, with MedAssets Supply Chain Systems, one of the largest Group Purchasing Organizations (GPOs) serving healthcare providers nationwide. The new three-year contract is effective April 1, 2010.

26 Apr 2010

SQI Diagnostics signs development agreement with Silliker

SQI Diagnostics Inc., a medical systems automation company focused on evolving laboratory-based biomarker testing, today announced that it has entered into a development agreement with Silliker, Inc., a leading internationally accredited company dedicated to improving nutrition, food safety and quality, for the commercialization of a botulism toxin panel that will run on SQI's SQiDman analytical system.

26 Apr 2010

Bowel cancer screening programme launched in Northern Ireland

The bowel cancer screening programme, which detects early signs of the disease, has been launched in Northern Ireland.

26 Apr 2010

Mimicking human nervous system for bionic applications can become a reality: Researchers

Mimicking the human nervous system for bionic applications could become a reality with the help of a method developed at Oak Ridge National Laboratory to process carbon nanotubes.

26 Apr 2010

Driving evolution of antibiotic resistance backwards

The use of antibiotics to treat bacterial infections causes a continual and vicious cycle in which antibiotic treatment leads to the emergence and spread of resistant strains, forcing the use of additional drugs leading to further multi-drug resistance.

26 Apr 2010

Charles River Laboratories International, WuXi PharmaTech sign definitive agreement to combine

Charles River Laboratories International, Inc., a leading global provider of research models and associated services and of preclinical drug development services, and WuXi PharmaTech, a leading drug research and development outsourcing company with expertise in discovery chemistry and with operations in China and the United States, today announced that they have signed a definitive agreement under which Charles River and WuXi will combine in a cash and stock transaction valued at approximately $1.6 billion.

26 Apr 2010

Serum cortisol levels linked with increased mortality in patients with ACS: Research

Growing evidence suggests that serum cortisol levels are associated with increased cardiovascular mortality in patients with chronic heart failure, research presented at this week's European Congress of Endocrinology shows.

26 Apr 2010

AlloMap molecular expression test reduces need for invasive heart-muscle biopsies

Monitoring rejection in heart transplantation patients with a simple blood test co-developed by NewYork-Presbyterian Hospital/Columbia University Medical Center physician-scientist Dr. Mario Deng in 2005 can safely reduce their need for invasive heart-muscle biopsies, a new study has found.

24 Apr 2010

Presidio Pharmaceuticals, Numerate conclude collaboration to discover new compounds targeting HCV

Presidio Pharmaceuticals, Inc., and Numerate, Inc., today announced that they have concluded their two-year collaboration to discover new compounds that target hepatitis C virus (HCV).

24 Apr 2010

New Actellic- 300CS demonstrates effective control of pyrethroid resistant mosquitoes

The Innovative Vector Control Consortium and Syngenta announced today that the latest field trials of the new Actellic- 300CS micro-encapsulated formulation demonstrate effective control of pyrethroid resistant mosquitoes on treated construction materials for more than eight months.

24 Apr 2010

McGill researchers receive $1.7M for 10 cutting-edge research projects

Ten McGill University researchers received an important boost today, by way of the announcement of $1.7 million in new funding awarded through the Canada Foundation for Innovation's Leaders Opportunity Fund. "CFI investments are critical for our research leaders, to ensure that their research remains innovative and second to none," said Dr. Rima Rozen, Interim Vice-Principal (Research and International Relations) at McGill.

24 Apr 2010

OrthoAccel Technologies' AcceleDent System receives award for excellence in design

OrthoAccel Technologies, Inc. announced this week that it received a Bronze Award at the 23rd Annual Excellence in Design competition. The AcceleDent System, which is an acceleration device to enhance orthodontics, was recognized by Appliance Design magazine in the Medical, Laboratory, & Test Equipment category.

24 Apr 2010

ICTP to participate in QWeCl project to help fight malaria and other vector-borne illnesses

The Abdus Salam International Centre for Theoretical Physics is taking part in a newly-launched, major international, European Union-funded project to help fight malaria and other vector-borne illnesses by developing and deploying an early warning system for disease outbreaks in Africa.

24 Apr 2010

Laboratory News and Research

Nurses who are interrupted while administering medication make errors: Report

VCA Antech's first-quarter 2010 revenue up 4.7% to $330.7M

ATCC introduces CRMs for method validation and method-performance verification

The Frost Group agrees to make investment in ChromaDex

Grape-enriched diet prevents risk factors for metabolic syndrome: Researchers

OICR makes equity investments in three promising Ontario technologies

Bruker to supply customized N8 TITANOS large sample AFM to US Commerce Department's NIST

IRIS International announces renewal of supply agreement with MedAssets Supply Chain Systems

SQI Diagnostics signs development agreement with Silliker

Bowel cancer screening programme launched in Northern Ireland

Mimicking human nervous system for bionic applications can become a reality: Researchers

Driving evolution of antibiotic resistance backwards

Charles River Laboratories International, WuXi PharmaTech sign definitive agreement to combine

Serum cortisol levels linked with increased mortality in patients with ACS: Research

AlloMap molecular expression test reduces need for invasive heart-muscle biopsies

Presidio Pharmaceuticals, Numerate conclude collaboration to discover new compounds targeting HCV

New Actellic- 300CS demonstrates effective control of pyrethroid resistant mosquitoes

McGill researchers receive $1.7M for 10 cutting-edge research projects

OrthoAccel Technologies' AcceleDent System receives award for excellence in design

ICTP to participate in QWeCl project to help fight malaria and other vector-borne illnesses

Viva Saliva Book: The ultimate guide to saliva Book preview Download eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo